IN THE COURT OF APPEALS OF THE STATE OF WASHINGTON

DIVISION II

In the Matter of the Detention of No. 53377-4-II

L.K.

PUBLISHED OPINION

WORSWICK, J. — Former RCW 71.05.215 (2018) establishes an involuntarily committed 

person’s right to refuse antipsychotic medication and requires that the State attempt to obtain 

such a person’s informed consent to treatment. The State is not relieved of this obligation 

merely because a physician believes an attempt to obtain informed consent would be futile. 

LK appeals a superior court order authorizing the involuntary administration of 

antipsychotic medications. LK argues that the State failed to attempt to obtain her informed 

consent as required by statute, thereby violating her right to due process and rendering the order 

authorizing the involuntary administration of antipsychotic medication unlawful. We agree,

reverse the superior court’s order, and remand to the superior court to vacate the order 

authorizing involuntary administration of antipsychotic medication. 

FACTS

LK was diagnosed with schizoaffective disorder, bipolar type, and has been hospitalized 

at Western State Hospital (WSH) six times, most recently in August 2017. In February 2019, 

while LK remained hospitalized, her psychiatrist at WSH, Dr. Nagavedu Raghunath, petitioned 

Filed

Washington State

Court of Appeals

Division Two

September 1, 2020
No. 53377-4-II

2

for an order granting the involuntary treatment of LK with antipsychotic medication. 

Specifically, Dr. Raghunath sought to treat LK with new medications: “Risperidone by mouth 

and later, Risperidone Long Acting Injectable; Fluphenazine Intramuscular if oral Risperidone 

refused.” Clerk’s Papers (CP) at 48. 

The day before the hearing on the petition, the State secured LK’s signature on a “twentyfour hour medication notice.” CP at 53. This notice documents LK’s understanding that she 

may refuse her medications the day prior to the hearing. LK indicated on the form that she 

agreed “to remain under medication as prescribed.” CP at 53.

The following day, at the hearing on the petition, Dr. Raghunath testified that LK was 

experiencing significant delusions. Dr. Raghunath explained that LK had responded well to 

treatment with Clozaril in the past, but in January she refused to take it. In February, she stopped 

all medications and began decompensating.

Dr. Raghunath testified that he had neither prescribed nor discussed treatment with 

risperidone or fluphenazine with LK. Instead, Dr. Raghunath focused on LK’s previous 

resistance to treatment with Clozaril:

Her kind of reason for not taking medication can vary [sic] anything from Clozaril 

needed regular blood draws to see how she is reacting to that, whether she is 

developing any kind of side effects to that. But she said that she has no blood in 

her body to give, and so she doesn’t want to have that medication. Then she said 

that it makes her too drowsy. She is not able to get up in the morning . . . . Then 

she also said that it makes her too tired during the day. So—and of course, she also 

said that she doesn’t think she needs that medication because she has no mental 

illness. 
No. 53377-4-II

3

Report of Proceedings (March 1, 2019) (RP) at 8. Dr. Raghunath acknowledged that “[n]o 

discussion has happened” with LK about the newly proposed treatment for which he sought 

authorization to involuntarily administer.

The superior court commissioner entered findings of fact and conclusions of law 

supporting an order authorizing involuntary treatment with antipsychotic medications. As to 

LK’s consent to treatment, the commissioner focused on Dr. Raghunath’s testimony about LK’s 

feelings toward treatment with Clozaril and found: “[LK] has refused to consent to treatment 

with antipsychotic medication for the following reasons[.] She says she does not have enough 

blood in her body, that it makes her tired and that she does not have a mental health disorder.” 

CP at 56. The commissioner concluded that LK may be involuntarily treated with the 

antipsychotic medication requested in the petition.

LK moved to revise the commissioner’s order. At a hearing before a superior court judge 

on the motion to revise, LK argued, in relevant part, that the State failed to attempt to obtain her 

informed consent to the proposed treatment. The superior court denied LK’s motion to revise. 

The superior court reasoned:

She’s not taking her medications. She’s refused medications for a variety of 

delusional beliefs. I think that an attempt to obtain informed consent from 

somebody who is actively psychotic, schizophrenic, threatening, abusive, 

disrobing, etc., is an exercise in futility. It’s not what I think the statute 

contemplated. 

. . . .

Informed consent also I think implies that the person has a degree of 

competency such that they can choose between an alternative course in a rational 

thought process, as opposed to a delusional belief system.

RP (March 22, 2019) at 20 (emphasis added). 
No. 53377-4-II

4

LK appeals the superior court’s order denying her motion to revise the commissioner’s 

ruling.

ANALYSIS

LK argues that the superior court violated former RCW 71.05.215, former RCW 

71.05.217 (2016), and her due process rights by affirming the order authorizing the involuntary 

administration of antipsychotic medications when the State had failed to attempt to obtain her 

informed consent. We agree.

I. LEGAL PRINCIPLES

A person “possesses a significant liberty interest in avoiding the unwanted administration 

of antipsychotic drugs under the Due Process Clause of the Fourteenth Amendment.” 

Washington v. Harper, 494 U.S. 210, 221-22, 110 S. Ct. 1028, 108 L. Ed. 2d 178 (1990). 

Moreover, an involuntarily committed person possesses a statutory right to refuse the 

administration of antipsychotic medication. Former RCW 71.05.215(1); former RCW 

71.05.217(7).1 But the right to refuse medication is not absolute. Our Supreme Court has 

recognized certain State interests that are sufficiently compelling to justify overriding a patient’s 

objection to medical treatment, including the preservation of life, the protection of interests of 

innocent third parties, the prevention of suicide, and the maintenance of the ethical integrity of 

the medical profession. In re Det. of Schuoler, 106 Wn.2d 500, 508, 723 P.2d 1103 (1986). 

 

1 Former RCW 71.05.215 and former RCW 71.05.217 are the statutes applicable to LK’s case. 

Both statutes were subsequently amended, most recently in 2020 by LAWS OF 2020, ch. 302, §§

30, 31. The amendments have no substantive impact on our analysis or holding.
No. 53377-4-II

5

The Due Process Clause of the United States Constitution requires procedural safeguards 

to ensure a person’s interests are taken into account before authorizing involuntary medication. 

Harper, 494 U.S. at 233. In Harper, the United States Supreme Court held that a Washington 

Department of Corrections policy for the involuntary administration of antipsychotic drugs to 

inmates satisfied constitutional due process requirements. 494 U.S. at 236. The policy entitled 

an inmate who refused to take medication, which a psychiatrist determined necessary, to a 

hearing before a special committee consisting of a psychiatrist, a psychologist, and the associate 

superintendent of the special offender center. Harper, 494 U.S. at 215. The inmate also had 

additional procedural rights surrounding the hearing, including the right to be informed of the 

tentative diagnosis, the factual basis for the diagnosis, and why the staff believed the medication 

to be necessary. Harper, 494 U.S. at 216. 

Following Harper, our legislature amended former RCW 71.05.215, which addresses a 

person’s right to refuse antipsychotic medication and instructs the Health Care Authority (HCA) 

to adopt rules to carry out the purposes of the chapter. See former RCW 71.05.215 (1997). The 

amendment included a requirement that the HCA’s rules include “[a]n attempt to obtain the 

informed consent of the person prior to administration of antipsychotic medication.” Former 

RCW 71.05.215(2)(a). Former RCW 71.05.215(2)(e) also required that the HCA’s rules include 

“documentation in the medical record of the attempt by the physician, physician assistant, or 

psychiatric advanced registered nurse practitioner to obtain informed consent and the reasons 

why antipsychotic medication is being administered over the person’s objection or lack of 

consent.”
No. 53377-4-II

6

Under former RCW 71.05.217(7)(a), a court may order the involuntary administration of 

antipsychotic medication if a petitioning party proves by clear, cogent, and convincing evidence 

that a compelling State interest exists to justify overriding the patient’s lack of consent, the 

proposed treatment is necessary and effective, and no medically acceptable alternative forms of 

treatment are available. Former RCW 71.05.217(7)(b) also requires that the superior court make 

specific findings of fact regarding “the person’s desires regarding the proposed treatment. If the 

patient is unable to make a rational and informed decision about consenting to or refusing the 

proposed treatment, the court shall make a substituted judgment for the patient as if he or she 

were competent to make such a determination.”

II. MOOTNESS AND STANDARD OF REVIEW

As an initial matter, although LK’s order has expired, this case is not moot because an 

order to involuntarily administer antipsychotic medication as part of LK’s prior medical history 

may have collateral consequences in future proceedings. In re Det. of B.M., 7 Wn. App. 2d 70, 

76, 432 P.3d 459, review denied, 193 Wn.2d 1017 (2019).

“On revision, the superior court reviews the commissioner’s findings of fact and 

conclusions of law de novo based on the evidence and issues presented to the commissioner.” 

Winter v. Dep’t of Social & Health Serv., 12 Wn. App. 2d 815, 829, 460 P.3d 667 (2020). 

“Under RCW 2.24.050, the findings and orders of a court commissioner not successfully revised 

become the orders and findings of the superior court.” Maldonado v. Maldonado, 197 Wn. App. 

779, 789, 391 P.3d 546 (2017). We review the superior court’s ruling, not the commissioner’s 

decision. See Flaggard v. Hocking, 13 Wn. App. 2d 252, 259, 463 P.3d 775 (2020). “When the 
No. 53377-4-II

7

standard is ‘clear, cogent, and convincing . . . the findings must be supported by substantial 

evidence in light of the ‘highly probable’ test.’” B.M., 7 Wn. App. 2d at 85 (quoting In re Det. of 

LaBelle, 107 Wn.2d 196, 209, 728 P.2d 138 (1986)). That is to say, “the ultimate fact in issue 

must be shown by evidence to be ‘highly probable.’” In re Welfare of Sego, 82 Wn.2d 736, 739, 

513 P.2d 831(1973).

III. AN ATTEMPT TO OBTAIN INFORMED CONSENT IS MANDATORY

LK argues that former RCW 71.05.215 and .217, read together, make mandatory the

attempt to obtain informed consent to administer antipsychotic medication. We agree. 

We review issues of statutory interpretation de novo. State v. C.B., 165 Wn. App. 88, 95, 

265 P.3d 951 (2011). “Our primary objective when interpreting a statute is to ascertain and give 

effect to the legislature’s intent.” C.B., 165 Wn. App. at 95. To do this, we begin by examining 

the statute’s plain language and according it its ordinary meaning. C.B., 165 Wn. App. at 95. 

Statutes that relate to the same subject matter are to be construed together as constituting a 

unified whole. Hallauer v. Spectrum Properties, Inc., 143 Wn.2d 126, 146, 18 P.3d 540 (2001).

“‘Statutes must be interpreted and construed so that all the language used is given effect, with no 

portion rendered meaningless or superfluous.’” G-P Gypsum Corp. v. Dep’t of Revenue, 169 

Wn.2d 304, 309 237 P.3d 256 (2010) (internal quotation marks omitted) (quoting State v. J.P.,

149 Wn.2d 444, 450, 69 P.3d 318 (2003)).

Former RCW 71.05.215(1) provides:

A person found to be gravely disabled or presents a likelihood of serious harm as a 

result of a mental disorder or substance use disorder has a right to refuse 

antipsychotic medication unless it is determined that the failure to medicate may 

result in a likelihood of serious harm or substantial deterioration or substantially 
No. 53377-4-II

8

prolong the length of involuntary commitment and there is no less intrusive course 

of treatment than medication in the best interest of that person.

To safeguard that right while balancing potential compelling State interests in treating 

such patients, former RCW 71.05.215(2) mandates the establishment of specific rules and states 

that these rules shall include “[a]n attempt to obtain the informed consent of the person prior to 

administration of antipsychotic medication.” In addition, former RCW 71.05.217(7)(b) requires

that the superior court make findings about “the person’s desires regarding the proposed 

treatment” before authorizing the involuntary administration of medication. It is axiomatic that a 

requirement to make such findings necessarily requires an attempt to obtain informed consent 

from the patient regarding the proposed medication. 

The State argues that the order here is valid because any attempt to obtain LK’s informed 

consent would have been futile. The State contends that the requirement to make an attempt to 

obtain informed consent is satisfied when the treating physician determines that an attempt 

would be futile because the patient lacks the competency to give informed consent.2 But neither 

the statutes nor due process principles permit any such nullification of a patient’s right to refuse 

antipsychotic medication. 

Neither former RCW 71.05.215 nor former RCW 71.05.217 provides that medical 

professionals may substitute their judgment for the procedures established by law to protect a 

person’s substantial liberty interest in refusing antipsychotic medication. Former RCW 

 

2 At oral argument, the State clarified that it was not arguing that it had to prove the respondent 

was legally incompetent, but instead that the court should rely on a physician’s medical 

judgment that the respondent would be unable to engage in a meaningful discussion regarding

their preference. Wash. Court of Appeals oral argument, In re Det. of LK, No. 53377-4-II (July 

1, 2020), at 11 min., 25 sec. through 12 min., 26 sec. (on file with court).
No. 53377-4-II

9

71.05.217(7)’s high burden for obtaining an order authorizing involuntary administration of 

medication contains no exception for patients a doctor determines is incompetent. Rather, the 

plain language of the statutes, read together, clearly mandates that the State attempt to obtain 

informed consent from all patients before seeking authorization for involuntary treatment. 

The State also contends that federal courts permit such a nullification, but its argument is 

unpersuasive. The State first cites Youngberg v. Romeo, 457 U.S. 307, 102 S. Ct. 2452, 73 L. 

Ed. 2d 28 (1982) (plurality opinion). But Youngberg did not involve the involuntary 

administration of antipsychotic medication. Youngberg involved a civil action for damages 

wherein a mentally disabled man in a state institution alleged that the State had violated his 

substantive due process rights to safe conditions of confinement, freedom from bodily restraints, 

and training or “habilitation.” The case addressed the proper standard of liability in such cases. 

457 U.S. at 325. The Supreme Court held that in determining whether the State had adequately 

protected a person’s rights, courts must show deference to the judgment exercised by a qualified 

professional, particularly when it came to a determination of what constitutes reasonable 

training. 457 U.S. at 324-25. Thus, Youngberg is not instructive here. 

The State next cites Rennie v. Klein, 720 F.2d 266, 269 (3d Cir. 1983) (plurality opinion),

for the premise that “antipsychotic drugs may be constitutionally administered to an involuntarily 

committed mentally ill patient whenever, in the exercise of professional judgment, such an action 

is deemed necessary to prevent the patient from endangering himself or others.” However, 

Rennie’s emphasis on deference to medical professional judgment was in regard to weighing the 

evidence of whether a patient constitutes a danger to themselves or to others when determining 
No. 53377-4-II

10

whether involuntary treatment is appropriate. See 720 F.2d 266 at 269. Rennie does not stand 

for the premise that a single medical professional’s determination of an involuntarily committed

patient’s inability to consent fulfills a statutory obligation to attempt to obtain informed consent 

sufficient to administer psychotropic medications. See also Harper, 494 U.S. at 233 (noting that 

adequate procedural safeguards existed where the independence of the decision-maker was 

addressed by barring the inmate’s current physician(s) from serving on the hearing committee).

The State argues that LK’s interpretation of former RCW 71.05.215 and former RCW 

71.05.217 elevates form over substance by requiring a “formulaic statement of the benefits and 

risks of the specific antipsychotic medications followed by a request for consent, which must be 

provided even if the patient has no ability to comprehend the information.” Br. of Resp’t at 12. 

On the contrary, the State’s contention that it need not discuss the proposed treatment with a 

patient in an attempt to obtain informed consent so long as the treating physician determines 

such an attempt would be futile would render former RCW 71.05.215(2)(a) meaningless. We 

interpret statutes so that no portion is rendered meaningless or superfluous. G-P Gypsum, 169 

Wn.2d at 309.

3

 

A physician must attempt to obtain informed consent before seeking an order authorizing 

involuntary administration of antipsychotic medication. We hold that a treating psychiatrist’s 

opinion that a patient is unable to give consent, formed before having any discussion with that 

 

3 Although we reject the State’s interpretation of the statute, even if we agreed with the State, the 

facts in this case would mandate reversal. The State cannot reconcile its argument that LK was 

incapable of giving informed consent while simultaneously obtaining her consent to continue her 

course of treatment 24 hours prior to her hearing. 
No. 53377-4-II

11

patient about the proposed treatment, is insufficient to satisfy the statutory requirement of 

attempting to obtain informed consent, and cannot, without more, form the basis of a superior 

court’s finding that the State sufficiently attempted to obtain informed consent.

IV. THE SUPERIOR COURT’S ORDER WAS UNLAWFUL

LK argues that because the State failed to attempt to obtain her informed consent, the 

superior court erred by granting the authorization for involuntary treatment. We agree. 

As discussed above, former RCW 71.05.215(2)(a) and former RCW 71.05.217(7)(b)

clearly require the State to attempt to obtain informed consent before involuntarily administering 

psychotropic medications. The State’s failure to attempt to obtain LK’s informed consent 

renders the order in this case unlawful. This result is further supported by Harper, 494 U.S. at

221. In Harper, the Court explicitly held that the Due Process clause of the Fourteenth 

Amendment requires certain essential procedural protections before the involuntary 

administration of medications to prisoners. 494 U.S. at 228. The Court went on to hold that a 

written State policy addressing such involuntary medication “undoubtedly confers upon 

respondent a right to be free from the arbitrary administration of antipsychotic medication,” and 

that the policy created an expectation on the part of the prisoners that drugs would not be 

administered in violation of the policy. Harper, 494 U.S. at 221. Such is the situation here.

In addition to the significant liberty interest every person maintains in avoiding the 

unwanted administration of antipsychotic medication under the federal due process clause, the 

mandatory nature of former RCW 71.05.215(2)(a) and former RCW 71.05.217(7)(b) create a 

protected liberty interest in avoiding involuntary treatment without an attempt to obtain informed 
No. 53377-4-II

12

consent. See Harper, 494 U.S. at 221. Former RCW 71.05.215(2)(a) and former RCW 

71.05.217(7)(b) create a justifiable expectation on the part of involuntarily committed persons 

that antipsychotic medication will not be administered unless an attempt to obtain their informed 

consent has been made. 

Here, the State never attempted to obtain LK’s informed consent to the proposed 

treatment. Although the superior court found that LK refused to consent to treatment, all 

evidence regarding LK’s refusal to be medicated was specific to LK’s comments about her prior

treatment with Clorazil. But the State was not seeking authorization for treatment with Clorazil. 

And former RCW 71.05.217(7)(b) expressly requires findings about the proposed treatment. See 

In re Det. of Strand, 167 Wn.2d 180, 188-89, 217 P.3d 1159 (2009) (statutory reference to “a 

current” evaluation was broader and more indeterminate than “the current” evaluation, thereby 

allowing for a future evaluation to be considered). Dr. Raghunath testified that no discussions 

regarding the proposed treatment with Risperdal or fluphenazine had occurred with LK.

The evidence shows that the State failed to fulfill its mandatory duty to seek LK’s 

informed consent. This failure violated former RCW 71.05.215(2)(a), former RCW 

71.05.217(7)(b), and LK’s right to due process. Accordingly, the commissioner’s order 

authorizing the involuntary administration of antipsychotic medication was unlawful, and the 

superior court erred by not granting LK’s motion to revise.

CONCLUSION

In conclusion, the State must attempt to obtain informed consent for the proposed 

treatment before seeking an order authorizing involuntary administration of antipsychotic 
No. 53377-4-II

13

medication. A treating psychiatrist’s opinion that a patient is unable to give consent, formed 

before having any discussion with that patient about the proposed treatment, is insufficient to 

satisfy the mandatory statutory requirement of attempting to obtain informed consent. This 

failure to attempt to obtain informed consent violated former RCW 71.05.215(2)(a), former 

RCW 71.05.217(7)(b), and LK’s due process rights. Accordingly, the commissioner’s order 

authorizing the involuntary administration of antipsychotic medication was unlawful, and the 

superior court erred by not granting LK’s motion to revise. 

We reverse and remand to the superior court to vacate the order authorizing involuntary 

administration of antipsychotic medication.

_________________________________

Worswick, J.

I concur:

_________________________________

Sutton, A.C.J.
No. 53377-4-II

14

MELNICK,J. (concurring) — I concur with the majority’s result. I write separately because 

I believe the majority’s holding is overbroad. 

Washington’s involuntary commitment laws require the State to adopt rules that “shall 

include . . . [a]n attempt to obtain the informed consent of the person prior to administration of 

antipsychotic medication.” RCW 71.05.215(2)(a). At the time of LK’s case, WAC 246-341-

1124(1)(a) applied and it required “[a]n attempt to obtain informed consent.” Consent is defined 

as: 

[An] agreement given by an individual after the person is provided with a 

description of the nature, character, anticipated results of proposed treatments and 

the recognized serious possible risks, complications, and anticipated benefits, 

including alternatives and nontreatment, that must be provided in a terminology 

that the person can reasonably be expected to understand. 

WAC 246-341-0200.

In the present case, the day before LK’s involuntary commitment hearing, the State 

obtained LK’s consent to remain under her currently prescribed medications. The notice stated 

that LK had been informed and understood she had a hearing set for the next day. 

At the hearing, the physician testified that no discussion with LK occurred about the new 

proposed treatment. The presiding superior court commissioner found that LK refused consent 

and could be involuntarily treated with the new medication. A superior court judge denied LK’s 

motion to revise. He opined that an attempt to obtain informed consent was “an exercise in 

futility.” Report of Proceedings (Mar. 22, 2019) at 20. 

In this case, the failure to attempt to obtain informed consent would not have been futile. 

In fact, the State obtained LK’s consent to continue her medications the day before the hearing. 
No. 53377-4-II

15

The facts do not support the State’s argument that any attempt to obtain informed consent would 

have been futile in this case. Rather, the facts demonstrate the opposite. 

However, I disagree with the majority that the failure to attempt to obtain informed consent 

is a due process violation. It is merely a statutory or rule violation.4 We should refrain from 

deciding a case on constitutional grounds unless it is absolutely necessary. Isla Verde Int’l 

Holdings, Inc. v. City of Camas, 146 Wn.2d 740, 752, 49 P.3d 867 (2002), abrogated on other 

grounds by Yim v. City of Seattle, 194 Wn.2d 682, 451 P.3d 694 (2019).

I also disagree with the majority’s treatment of the statute’s interpretation on futility. First, 

we are not presented with that situation in this case and we should not decide the issue. Ruse v. 

Dep’t of Labor & Indus., 138 Wn.2d 1, 8-9, 977 P.2d 570 (1999). Second, there may be situations 

not present here, where an attempt to obtain informed consent may be a futile gesture. As an 

example, RCW 10.31.040, known colloquially as the knock and announce statute, states that an 

officer may break open the doors or windows of a residence or building “if, after notice of his or 

her office and purpose, he or she be refused admittance.” Although there are no statutory 

exceptions, it is well-settled that “useless gestures” excuse compliance with RCW 10.31.040. State 

v. Coyle, 95 Wn.2d 1, 11, 621 P.2d 1256 (1980); State v. Shelly, 58 Wn. App. 908, 911, 795 P.2d 

187 (1990). 

 

4 LK argues that due process requires an attempt to obtain informed consent from an involuntarily 

committed person before antipsychotic medications are administered. LK relies on Washington v. 

Harper, 494 U.S. 210, 110 S. Ct 1028, 108 L. Ed. 2d 178 (1990); however, Harper does not stand 

for that proposition. Harper’s holding is that an administrative hearing, and not a judicial hearing, 

is required before a person can be treated with antipsychotic drugs against the person’s will. 

Harper, 494 U.S. at 231. 
No. 53377-4-II

16

Similar to knock and announce cases, I can envision situations where a “futile action” may 

excuse compliance with a doctor attempting to obtain informed consent. I would speculate that 

any such exception would be narrowly drawn. However, this issue is not before us in this case 

and I believe the majority’s holding is overbroad. I respectfully concur. 

Melnick, J.